Form 4: Core Labs Officer Reports Stock Transactions

Core Laboratories Inc. SVP Mark Tattoli reported the acquisition of 250 common shares and disposition of 99 shares related to restricted stock vesting.

Summary

• Mark Damian Tattoli, SVP, General Counsel & Secretary of Core Laboratories Inc. (CLB), reported transactions on August 1, 2025.
• Acquired 250 shares of common stock through the exercise or conversion of derivative securities at a price of $0.
• Disposed of 99 shares of common stock at $10.53 per share, likely for tax withholding related to the vesting of restricted shares.
• Following these transactions, direct beneficial ownership of common stock is 16,393.621 shares.
• Indirect beneficial ownership includes 20 shares in a custodial account and 1,694.842 shares in a 401(k) Plan.
• The filing also notes 2,150 restricted shares beneficially owned, which vest annually over six years.

Sentiment

Score: 6

Explanation: The filing indicates an officer's acquisition of shares through vesting of restricted stock, which is generally a positive sign of continued alignment with shareholder interests, despite a small disposition for tax purposes.

Positives

• Acquisition of 250 common shares through the exercise of derivative securities, increasing direct beneficial ownership.
• The vesting of restricted shares indicates continued long-term incentive alignment with the company's performance.

Negatives

• Disposition of 99 shares, likely for tax purposes, reduces the total number of shares held directly.

Future Outlook

No forward-looking statements or guidance are provided.

Industry Context

This is an insider transaction report, which primarily reflects individual executive compensation and ownership changes rather than broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The officer's increased direct ownership (net of tax sales) aligns executive interests with shareholder value.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to executive compensation (restricted stock vesting and tax withholding). It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The net increase in shares held by the officer is a minor positive for alignment but not a strong buy signal on its own.

Keywords

Core Laboratories, CLB, SEC Form 4, Insider Trading, Stock Transactions, Restricted Stock, Executive Compensation, Mark Tattoli, Beneficial Ownership